Issue 92, 2015

Low-dose HSP90 inhibitors DPB and AUY-922 repress apoptosis in HUVECs

Abstract

In this study, we found that low-dose HSP90 inhibitors DPB and AUY-922 could unexpectedly restrain apoptosis in HUVECs. This hormesis was accompanied by the increase of p-AKT1. Our findings could have significant implications for the administration of HSP90 inhibitors in vascular diseases and cancer.

Graphical abstract: Low-dose HSP90 inhibitors DPB and AUY-922 repress apoptosis in HUVECs

Supplementary files

Article information

Article type
Communication
Submitted
10 Jun 2015
Accepted
03 Sep 2015
First published
03 Sep 2015

RSC Adv., 2015,5, 75753-75755

Author version available

Low-dose HSP90 inhibitors DPB and AUY-922 repress apoptosis in HUVECs

S. Bai, L. Yao, L. Su, S. Zhang, B. Zhao and J. Miao, RSC Adv., 2015, 5, 75753 DOI: 10.1039/C5RA10989B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements